This is a type of antifungal medicine used to treat serious fungal infections. It works by stopping the growth of certain fungi. It's often given in the hospital.
Every report comes from a Lived member, sent anonymously.
Have you tried Caspofungin for Invasive Candidiasis?
Caspofungin, sold under the brand name Cancidas and also available as a generic, is an intravenous antifungal medicine used for serious fungal infections, usually in the hospital. It is approved for adults and children 3 months and older. Its main use is treating invasive Candida infections, which are caused by a type of yeast. These include candidemia (Candida in the bloodstream) and Candida infections inside the abdomen or in the space around the lungs. US infectious disease guidelines recommend caspofungin or a closely related medicine as the usual first treatment for candidemia. It is also approved for Candida infection of the esophagus, the tube that carries food to the stomach, though not for thrush limited to the mouth and throat. Caspofungin is also given to people with a fever and a very low white blood cell count (neutropenia, often after chemotherapy or a stem cell transplant) when doctors suspect a fungal infection before one has been confirmed. Finally, it can treat invasive aspergillosis, a mold infection usually of the lungs, in people whose infection has not responded to other antifungals or who cannot tolerate them. It is not a standard first choice for aspergillosis.
Fungal cells are surrounded by a tough cell wall that holds their shape. A key building block of that wall is a sugar chain called beta-glucan. Caspofungin belongs to a class of antifungals called echinocandins, which block the enzyme fungi use to make beta-glucan. Without it, the wall weakens and the fungus cannot grow normally; Candida cells are often killed outright. Human cells have no cell wall and do not make beta-glucan, which is one reason echinocandins tend to be well tolerated. Caspofungin works against Candida and Aspergillus, but not against all fungi, and some Candida strains have become resistant, so the laboratory identification of the organism helps guide treatment.
Caspofungin is given only through an IV, as a slow infusion that runs over about an hour, once a day. There is no pill form. Treatment usually starts with a larger first dose on day one, followed by a standard daily dose. Children's doses are calculated from body size, with a cap at the adult maximum. The care team handles preparation and dosing. People with moderate liver problems usually receive a lower daily dose. No adjustment is needed for kidney problems, and dialysis does not remove the drug. The dose may be raised for people taking certain medicines that speed up its breakdown, described below. The length of treatment depends on the infection and how the person responds. For a bloodstream Candida infection, treatment typically continues for at least two weeks after blood cultures turn negative.
Fever, chills, diarrhea, nausea, headache and rash are among the effects reported most often, although in very ill people it can be hard to tell which effects come from the medicine and which from the infection. Routine blood tests often show raised liver enzymes or low potassium, which the care team watches for and corrects. In children, low blood pressure and chills during treatment are also common. Some people have a reaction during the infusion, such as flushing, a feeling of warmth, itching, rash or facial swelling. Serious allergic reactions, including anaphylaxis, are rare. Tell the nurse right away about trouble breathing, wheezing, or swelling of the face, lips or throat so the infusion can be stopped. Rarely, caspofungin has been linked to severe skin reactions. Blistering, peeling or a painful spreading rash needs to be reported to the care team immediately. Isolated cases of serious liver injury have occurred in people with other serious illnesses who were taking many medicines, though it is not clear that caspofungin was the cause.
Caspofungin should not be used by anyone who has had a serious allergic reaction to it. Several interactions matter for people who have had a transplant. Cyclosporine, a medicine that prevents organ rejection, raises caspofungin levels, and the combination has caused raised liver enzymes, so it is used only when the benefit outweighs that risk and with liver monitoring. People taking tacrolimus, another anti-rejection medicine, need their tacrolimus blood levels checked as usual. Rifampin, an antibiotic used for tuberculosis, lowers caspofungin levels, so a higher daily dose is used. A similar increase may be considered with some seizure medicines (phenytoin, carbamazepine), the HIV medicines efavirenz and nevirapine, and the steroid dexamethasone. Animal studies suggest caspofungin could harm a developing baby, and there is not enough human information to know the risk. It is not known whether caspofungin passes into breast milk. Anyone who is pregnant, could be pregnant or is breastfeeding should discuss this with the care team, weighed against the danger of an untreated serious fungal infection.
Most people receive caspofungin while in the hospital, though some finish a course through home or clinic infusion. Expect daily infusions, regular blood tests to check liver function and potassium, and, for bloodstream infections, repeat blood cultures to confirm the infection is clearing. Improvement in fever and other symptoms is a sign the medicine is working, but treatment continues past that point to prevent the infection from returning. For a bloodstream Candida infection, people who are stable, whose yeast is sensitive to fluconazole (an oral antifungal) and whose blood cultures have cleared are often switched to fluconazole tablets, commonly after five to seven days. How long treatment lasts depends heavily on the underlying situation. People with neutropenia may need longer treatment until their white blood cell count recovers, and people with aspergillosis are treated according to how severe the infection is and how well their immune system recovers. Outcomes depend as much on the person's overall health and the infection's source, such as an infected IV line that may need removal, as on the antifungal itself.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Caspofungin, what you've noticed, or ask the community a question.